Potential for prevention of infection by green tea

Green Tea and Health: Antioxidant Properties, Consumption and Role in Disease Prevention

Volumn , Issue , 2015, Pages 19-32

  Reygaert, Wanda C ^a  

^a OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84960304236     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (86)

1. World Health Organization, World Health Statistics 2014. 2014b.
2. Scott, R.D. The direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention. Centers for Disease Control, 2009; pub. #CS200891-A.
3. Huang, S.S., Johnson, K.M., Ray, G.T., Wroe, P., Lieu, T.A., Moore, M.R., et al., Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine, 2011; 29: 3398-3412.
4. U.S. Department of Health and Human Services Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013.
5. World Health Organization. Antimicrobial resistance: Global report on surveillance, 2014. 2014a.
6. Filice, G.A., Nyman, J.A., Lexau, C., Lees, C.H., Bockstedt, L.A., Como-Sabetti, K., et al., Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection. Infect. Control. Hosp. Epidemiol., 2010; 31: 365-373.
7. Hübner, C., Hübner, N.O., Hopert, K., Maletzki, S., Flessa, S. Analysis of MRSAattributed costs of hospitalized patients in Germany. Eur. J. Clin. Microbiol. Infect. Dis., 2014; 33: 1817-1822.
8. Macedo-Viñas, M., De Angelis, G., Rohner, P., Safran, E., Stewardson, A., Fankhauser, C., et al., Burden of methicillin-resistnat Staphylococcus aureus infections at a Swiss University hospital: excess length of stay and costs. J. Hosp. Infect., 2013; 84: 132-137.
9. Gupta, D.A., Bhaskar, D.J., Gupta, R.K., Karim, B., Jain, A., Dalai, D.R. Green tea: a review on its natural anti-oxidant therapy and cariostatic benefits. Biol. Sci. Pharm. Res., 2014; 2:8-12.
10. Jigisha, A., Nishant, R., Navin, K., Pankaj, G. Green tea: a magical herb with miraculous outcomes. Int. Res. J. Pharm. 2012; 3: 139-148.
11. Cabrera, C., Artacho, R., Gimenez, R. Beneficial effects of green tea - a review. J. Am. Coll. Nutr. 2006; 25: 79-99.
12. Serafini, M., Del Rio, D., Yao, D.N., Bettuzzi, S., Peluso, I. "Health benefits of tea", in Herbal Medicine: Biomolecular and clinical Aspects, 2nd ed., Chapter 12, eds I.F.F. Benzie and S. Wachtel-Galor (Boca Raton, FL; CRC Press), 239-262, 2011.
13. Subramani, C., Natesh, R.K., Molecular mechanisms and biological implications of green tea polyphenol, (-)-epigallocatechin-3-gallate. Int. J. Pharm. Biosci. Tech. 2013; 1: 54-63.
14. Li, M.J., Yin, Y.C., Wang, J., Jiang, Y.F. Green tea compounds in breast cancer prevention and treatment. World J. Clin. Oncol., 2014; 5(3): 520-528.
15. Khan, N, Mukhtar, H. Modulation of signaling pathways in prostate cancer by green tea polyphenols. Biochem. Pharmacol., 2013; 85(5): 667-672. doi:10.1016/j.bcp.2012.09.027.
16. Gupta, K., Thakur, V.S., Bhaskaran, N., Nawab, A., Babcook, M.A., Jackson, M.W., Gupta, S. Green tea polyphenols induce p53-dependent and p53-independent apoptosis in prostate cancer cells through two distinct mechanisms. PloS One. 2012; 7(12): e52572.
17. Singh, T., Katiyar, S.K. Green tea polyphenol, (-)-epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting ß-catenin signaling. Toxicol. Appl. Pharmacol. 2013; 273(2): 418-424.
18. Sonoda, J.I., Ikeda, R., Baba, Y., Narumi, K., Kawachi, A., Tomishige, E., et al., Green tea catechin, epigallocatechin-3-gallate, attenuates the cell viability of human nonsmall-cell lung cancer A549 cells via Bcl-xL expression. Exp. Ther. Med. 2014; 8(1): 59-63.
19. Henning, S.M., Wang, P., Carpenter, C.L., Heber, D. Epigenetic effects of green tea polyphenols in cancer. Epigenomics. 2013; 5(6): 729-741.
20. Ahmed, S., Marotte, H., Kwan, K., Ruth, J.H., Campbell, P.L., Rabquer, B.J., et al., Epigallocaetchin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production. Proc Natl Acad Sci USA, 2008; 105(38): 14692-14697.
21. Yun, H.J., Yoo, W.H., Han, M.K., Lee, Y.R., Kim, J.S., Lee, S.I. Epigallocatechin-3-gallate suppresses TNF-a-induced production of MMP-1 and -3 in rheumatoid arthritis synovial fibroblasts. Rheumatol. Int., 2008; 29(1): 23-29.
22. Leong, D.J., Choudhury, M., Hanstein, R., Hirsh, D.M., Kim, S.J., Majeska, R.J., et al., Green tea polyphenol treatment is chondroprotective, anti-inflammatory and palliative in a mouse posttraumatic osteoarthritis model. Arthritis Res. Ther., 2014; 16(6): 508.
23. Chatterjee, P., Chandra, S., Dey, P., Bhattacharya, S. Evaluation of anti-inflammatory effects of green tea and black tea: a comparative in vitro study. J. Adv. Pharm. Technol. Res., 2012; 3(2): 136-138.
24. Newsome, B.J., Petriello, M.C., Han, S.G., Murphy, M.O., Eske, K.E., Sunkara, M., et al., Green tea diet decreases PCB 126-induced oxidative stress in mice by upregulating antioxidant enzymes. J. Nutr. Biochem., 2014; 25(2): 126-135.
25. Tsai, C.F., Hsu, Y.W., Ting, H.C., Huang, C.F., Yen, C.C. The in vivo antioxidant and antifibrotic properties of green tea (Camellia sinensis, Theaceae). Food Chem., 2013; 136(3-4): 1337-1344.
26. Ohmori, R., Kondo, K., Momiyama, Y. Antioxidant beverages: green tea intake and coronary artery disease. Clin. Med. Insights Cardiol., 2014; 8(Suppl 3): 7-11.
27. Li, M., Liu, J.T., Pang, X.M., Han, C.J., Mao, J.J. Epigallocatechin-3-gallate inhibits angiotensin II and interleukin-6-induced C-reactive protein production in macrophages. Pharmacol. Rep., 2012; 64: 912-918.
28. Narotzki, B., Levy, Y., Aizenbud, D., Reznick, A.Z. Green tea and its major polyphenol EGCG increase the activity of oral peroxidases. Adv. Exp. Med. Biol., 2013; 756: 99-104.
29. Rassameemasmaung, S., Phusudswang, P., Sangalungkarn, V. Effect of green tea mouthwash on oral malodor. ISRN Prev. Med. 2012, 2013:975148.
30. Kushiyama, M., Shimazaki, Y., Murakami, M., Yamashita, Y. Relationship between intake of green tea and periodontal disease. J. Peridontol., 2009; 80: 372-377.
31. Kato, M.T., Magalhães, A.C., Rios, D., Hannas, A.R., Attin, T., Buzalaf, M.A. Protective effect of green tea on dentin erosion and abrasion. J. Appl. Oral Sci., 2009; 17(6): 560-564.
32. Wang, Y., Ho, C.T. Polyphenolic chemistry of tea and coffee: a century of progress. J. Agric. Food Chem., 2009; 57: 8109-8114.
33. Roowi, S., Stalmach, A., Mullen, W., Lean, M.E., Edwards, C.A., Crozier, A. Green tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humans. J. Agric. Food Chem., 2010; 58: 1296-1304.
34. Fernandez, P.L., Pablos, F., Martin, M.J., Gonzalez, A.G. Study of catechin and xanthine tea profiles as geographical tracers. J. Agric. Food Chem., 2002; 59: 1833-1839.
35. Lin, Y.S., Tsai, Y.J., Tsay, J.S., Lin, J.K. Factors affecting the levels of tea polyphenols and caffeine in tea leaves. J. Agric. Food Chem., 2003; 51: 1864-1873.
36. Sourabh, A., Kanwar, S.S., Sud, R.G., Ghabru, A., Sharma, O.P. Influence of phenolic compounds of Kangra tea [Camellia sinensis (L) O Kuntze] on bacterial pathogens and indigenous bacterial probiotics of Western Himalayas. Braz. J. Microbiol. 2014; 44(3): 709-715.
37. Stalmach, A., Troufflard, S., Serafini, M., Crozier, A. Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans. Mol. Nutr. Food Res., 2009; 53: S44-S53.
38. Clifford, M.N., van der Hooft, J.J., Crozier, A. Human studies on the absorption, distribution, metabolism, and excretion of tea polyphenols. Am. J. Clin. Nutr., 2013; 98: 1619S-1630S.
39. Lee, M.J., Wang, Z.Y., Li, H., Chen, L., Sun, Y., Gobbo, S., et al., Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol. Biomarkers Prev., 1995; 4: 393-399.
40. Yang, C.S., Chen, L., Lee, M.J., Balentine, D, Kuo, M.C., Schantz, S.P. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomarkers Prev., 1998; 7:351-354.
41. Chow, H.H., Cai, Y., Alberts, D.S., Hakim, I., Dorr, R., Shahi, F., et al., Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol. Biomarkers Prev., 2001; 10: 53-58.
42. Van Amelsvoort, J.M., Van Hof, K.H., Mathot, J.N., Mulder, T.P., Wiersma, A., Tijburg, L.B. Plasma concentrations of individual tea catechins after a single oral dose in humans. Xenobiotica, 2001; 31: 891-901.
43. Clarke, K.A., Dew, T.P., Watson, R.E., Farrar, M.D., Bennett, S., Nicolaou, A., et al., High performance liquid chromatography tandem mass spectrometry dual extraction method for identification of green tea catechin metabolites excreted in human urine. J. Chromatogr.B., 2014; 1: 972-937.
44. Reygaert, W.C. The antimicrobial possibilities of green tea. Front. Microbiol., 2014; 5: 434.
45. Nakagawa, K., Okuda, S., Miyazawa, T. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci. Biotechnol. Biochem., 1997; 61: 1981-1985.
46. Chow, H.H., Cai, Y., Hakim, I.A., Crowell, J.A., Shahi, F., Brooks, C.A., et al., Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin. Cancer Res., 2003; 9: 3312-3319.
47. Ullmann, U., Haller, J., Decourt, J.P., Girault, N., Girault, J., Richard-Caudron, A.S., et al., A single ascending dose study of epigallocatechin gallate in healthy volunteers. J. Int. Med. Res., 2003; 31 88-101.
48. Renouf, M., Marmet, C., Guy, P.A., Beaumont, M., Lepage, M, Williamson, G, et al., Dose-response plasma appearance of green tea catechins in adults. Mol. Nutr. Food Res., 2013; 57: 833-839.
49. Suganuma, M., Okabe, S., Oniyama, M., Tada, Y., Ito, H., Fujiki, H. Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis, 1998; 19(10): 1771-1776.
50. Swezey, R.R., Aldridge, D.E., LeValley, S.E., Crowell, J.A., Hara, Y., Green, C.E. Absorption, tissue distribution and elimination of 4-[3)h]-epigallocatechin gallate in beagle dogs. Int. J. Toxicol., 2003; 22(3): 187-193.
51. Rhodes, L.E., Darby, G., Massey, K.A., Clarke, K.A., Dew, T.P., Farrar, M.D., et al., Oral green tea catechin metabolites are incorporated nito human skin and protect against UV radiation-induced cutaneous inflammation in association with reduced production of pro-inflammatory eicosanoid 12-hydroxyeicosatetraenoic acid. Br. J. Nutr., 2013; 110(5): 891-900.
52. Sirk, T.W., Brown, E.F., Sum, A.K., Friedman, M. Molecular dynamics study on the biophysical interactions of seven green tea catechins with lipid bilayers of cell membranes. J. Agric. Food Chem., 2008; 56: 7750-7758.
53. Sirk, T.W., Brown, E.F., Friedman, M., Sum, A.K. Molecular binding of catechins to biomembranes: relationship to biological activity. J.Agric. Food Chem., 2009; 57: 6720-6728.
54. Cho, Y.S., Schiller, N.L., Kahng, H.Y., Oh, K.H. Cellular responses and proteomic analysis of Escherichia coli exposed to green tea polyphenols. Curr. Microbiol., 2007; 55: 501-506.
55. Ikigai, H., Nakae, T., Hara, Y., Shimamura, T. Bactericidal catechins damage the lipid bilayer. Biocim. Biophys. Acta, 1993; 1147: 132-136.
56. Sharma, A., Gupta, S., Sarethy, I.P., Dang, S., Gabrani, R. Green tea extract: possible mechanism and antibacterial activity on skin pathogens. Food Chem., 2012; 135: 672-675.
57. Blanco, A.R., Sudano-Roccaro, A., Spoto, G.C., Nostro, A., Rusciano, D. Epigallocatechin gallate inhibits biofilm formation by ocular staphylococcal isolates. Antimicrob. Agents Chemother., 2005; 49: 4339-4343.
58. Sugita-Konishi, Y., Hara-Kudo, Y., Amano, F., Okubo, T., Aoi, N., Iwaki, M., et al., Epigallocatechin gallate and gallocatechin gallate in green tea catechins inhibit extracellular release of vero toxin from enterohemorrhagic Escherichia coli O157:H7. Biochim. Biophys. Acta, 1999; 1472: 42-50.
59. Shah, S., Stapleton, P.D., Taylor, P.W. The polyphenol (-)-epicatechin gallate disrupts the secretion of virulence-related proteins by Staphylococcus aureus. Lett. Appl. Microbiol., 2008; 46: 181-185.
60. Wang, Y., Ma, S. Recent advances in inhibitors of bacterial fatty acid synthesis type II (FASII) system enzymes as potential antibacterial agents. Chem MedChem, 2013; 8(10): 1589-1608.
61. Zhang, Y.M., Rock, C.O. Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthesis. J. Biol. Chem., 2004; 279: 30994-31001.
62. Li, B.H., Zhang, R., Du, Y.T., Sun, Y.H., Tian, W.X. Inactivation mechanism of the beta-ketoacyl-[acyl carrier protein] reductase of bacterial type-II fatty acid synthesis by epigallocatechin gallate. Biochem. Cell Biol., 2006; 84: 755-762.
63. Sakanaka, S., Okada, Y. Inhibitory effects of green tea polyphenols on the production of a virulence factor of the periodontal-disease-causing anaerobic bacterium Porphyromonas gingivalis. J. Agric. Food Chem., 2004; 52: 1688-1692.
64. Okamoto, M., Leung, K.P., Ansai, T., Sugimoto, A., Maeda, N. Inhibitory effects of green tea catechins on protein tyrosine phosphatase in Prevotella intermedia. Oral Microbiol. Immunol., 2003; 18: 192-195.
65. Okamoto, M., Sugimoto, A., Leung, K.P., Nakayama, K., Kamaguchi, A., Maeda, N. Inhibitory effect of green tea catechins on cysteine proteinases in Porphyromonas gingivalis. Oral Microbiol. Immunol., 2004; 19: 118-120.
66. Grandišar, H., Pristovšek, P., Plaper, A., Jerala, R. Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site. J. Med. Chem., 2007; 50: 264-271.
67. Navarro-Martinez, M.D., Navarro-Peran, E., Cabezas-Herrera, J., Ruiz-Gomez, J., Garcia-Canovas, F., Rodriguez-Lopez, J.N. Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophilia. Antimicrob. Agents Chemother., 2005; 49: 2914-2920.
68. Navarro-Martinez, M.D., Garcia-Canovas, F., Rodriguez-Lopez, J.N. Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans. J. Antimicrob. Chemother., 2006; 57: 1083-1092.
69. Chinnam, N., Dadi, P.K., Sabri, S.A., Ahmad, M., Kabir, M.A., Ahmad, Z. Dietary bioflavonoids inhibit Escherichia coli ATP synthesis in a differential manner. Int. J. Biol., 2010; 46: 478-486.
70. Yam, T.S., Hamilton-Miller, J.M., Shah, S. The effect of a component of tea (Camellia sinensis) on methicillin resistance, PBP2' synthesis, and beta-lactamase production in Staphylococcus aureus. J. Antimicrob. Chemother., 1998; 42: 211-216.
71. Zhao, W.H., Hu, Z.Q., Hara, Y., Shimamura, T. Inhibition by epigallocatechin gallate (EGCg) of conjugative R plasmid transfer in Escherichia coli. J. Infect. Chemother., 2001; 7: 195-197.
72. Sudano Roccaro, A., Blanco, A.R., Giuliano, F., Rusciano, D., Enea, V. Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells. Antimicrob. Agents Chemother., 2004; 48: 1968-1973.
73. Lee, K.M., Yeo, M., Choue, J.S., Jin, J.H., Park, S.J., Cheong, J.Y., et al., Protective mechanism of epigallocatechin-3-gallate against Helicobacter pylori-induced gastric epithelial cytotoxicity via the blockage of TLR-4 signaling. Helicobacter, 2004; 9: 632-642.
74. Williamson, M.P., McCormick, T.G., Nance, C.L., Shearer, W.T. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: potential for HIV-1 therapy. J. Allergy Clin. Immunol., 2006; 118: 1369-1374.
75. Fink, R.C., Roschek, B., Jr., Alberte, R.S. HIV type-1 entry inhibitors with a new mode of action. Antivir. Chem. Chemother., 2009; 19(6): 243-255.
76. Yang, J., Li, L, Tan, S., Jin, H., Qiu, J., Mao, Q., et al., A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: potential applications for preventing HIV-1 infection. Fitoterapia, 2012; 83: 348-355.
77. Hauber, H., Hohenberg, H., Holstermann, B., Hunstein, W., Hauber, J. The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection. Proc. Natl. Acad. Sci., 2009; 106(22): 9033-9038.
78. Lin, Y.T., Wu, Y.H., Tseng, C.K., Lin, C.K., Chen, W.C., Hsu, Y.C., et al., Green tea epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus-induced inflammation. PloS One, 2013; 8(1): e54466.
79. Liu, S., Li, H., Chen, L., Yang, L., Li, L., Tao, Y., et al., (-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic cycle infection involves ERK1/2 and PI3-K/Akt signaling in EBV-positive cells. Carcinogenesis, 2013; 34(3): 627-637.
80. Reygaert, W., Jusifi, I. Green tea as an effective antimicrobial for urinary tract infections caused by Escherichia coli. Front. Microbiol., 2013; 4: 162.
81. Stoicov, C., Saffari, R., Houghton, J.M. Green tea inhibits Helicobacter growth in vivo and in vitro. Int. J. Antimicrob. Agents, 2009; 33(5): 473-478.
82. Noda, T., Ojima, T., Hayasaka, S., Murata, C., Hagihara, A. Gargling for oral hygiene and the development of fever in childhood: a population study in Japan. J. Epidemiol., 2012; 22(1): 45-49.
83. Rowe, C.A., Nantz, M.P., Bukowski, J.F., Percival, S.S. Specific formulation of Camellia sinensis prevents cold and flu symptoms and enhances gamma,delta T cell function: a randomized, double-blind, placebo-controlled study. J. Am. Coll. Nutr., 2007; 26(5): 445-452.
84. Oxford, J.S., Lambkin, R., Guralnik, M., Rosenbloom, R.A., Petteruti, M.P., DiGian, K., et al., In vivo prophylactic activity of QR-435 against H3N2 Influenza virus infection. Am. J. Ther., 2007; 14(5): 462-468.
85. Matsumoto, K., Yamada, H., Takuma, N., Niino, H., Sagesaka, Y.M. Effects of green tea catechins and theanine on preventing influenza infection among healthcare workers: a randomized controlled trial. BMC Complement. Altern. Med., 2011; 11:15.
86. Park, M., Yamada, H., Matsushita, K., Kaji, S., Goro, T., Okada, Y., et al., Green tea consumption is inversely associated with the incidence of influenza infection among schoolchildren in a tea plantation area of Japan. J. Nutr., 2011; 141(10): 1862-1870.